Learn More
The role of the dual HER2 inhibition, and the best chemotherapy backbone for neoadjuvant chemotherapy still represent an issue for clinical practice. A literature-based meta-analysis exploring single(More)
PURPOSE A correlation, power and benchmarking analysis between progression-free and overall survival (PFS, OS) of randomized trials with targeted agents or immunotherapy for advanced renal cell(More)
399 Background: To predict the clinical benefit of TA in mRCC, several studies have analyzed some angiogenesis-related biomarkers including soluble VEGF and VEGF-Receptors, VEGF polymorphisms, IL-8(More)